Clinical Trials in Colorado

Showing 181-200 of 8,657 trials

A Study to Evaluate 0.003% AR-15512 Safety and Drop Attributes

NCT06660290

The purpose of this study is to evaluate the percentage of ocular adverse events reported in subjects with dry eye disease (DED) between the intervention arm (0.003% AR-15512) and control arm (REFRESH® Classic).

Dry Eye Disease

Alcon Research55 participantsStarted Jan 2025

Newport Beach, California, United States • Colorado Springs, Colorado, United States • Andover, Massachusetts, United States +3 more locations

RECRUITINGPHASE250 miles

A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)

NCT07015983

The purpose of this study is to evaluate the efficacy, safety and drug levels of CC-97540 in participants with active systemic lupus erythematosus (SLE) including lupus nephritis with inadequate response to glucocorticoids and at least 2 immunosuppressants.

Lupus Erythematosus, SystemicLupus Nephritis

Juno Therapeutics, Inc., a Bristol-Myers Squibb Company89 participantsStarted Jul 2025

Birmingham, Alabama, United States • Scottsdale, Arizona, United States • Scottsdale, Arizona, United States +99 more locations

A Study to Evaluate 0.003% AR-15512 Safety and Drop Attributes

A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)

Find Trials by Condition in Colorado

PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease

Evolut™ EXPAND TAVR II Pivotal Trial

Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors

ELEVATE High-Risk PCI Pivotal Study

A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL

Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis

Study of PIT565 in Relapsed and/or Refractory B-cell Malignancies

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

A Long-term Safety and Efficacy Study of Danicopan as an Add-on Therapy to Complement Component 5 Inhibitor (C5i) in Participants With PNH

Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease

A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes

AXIOS™ Gastroenterostomy for Gastric Outlet Obstruction IDE

Actinium Therapy for Late-stage Aggressive Sarcomas

rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG

Empathic Communication Skills (ECS) Training

A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

Donidalorsen Treatment in Children With Hereditary Angioedema